Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04308382 · ClinicalTrials.gov registry record
Evaluation of a Corporate Wellness Program
A clinical trial, sponsored by Ohio University.
- Completed
- Registry status
- 500
- Enrollment target
NCT04308382: Completed study, sponsored by Ohio University.
NCT04308382 is a clinical trial that has completed, run by Ohio University. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04308382 has completed, sponsored by Ohio University.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
The purpose of this project is to determine the effectiveness of the corporate wellness program at Memorial Health System (MHS) in regards to: 1. Improvement of health of employees 2. Savings on health care expenses The corporate wellness program itself is not the object of the study, but rather the results of the program are the focus. The program will be a dynamic process, changing over time to address the needs of the hospital system employees. This study will look at the effects of the program as a whole to impact employee health and the cost of healthcare. This study will also evaluate individual components of the program (physical activity, stress management, etc) to determine specific benefits of those components to those who participate.
Primary Outcome
Cost for health care as a corporation
Interventions
- BEHAVIORAL Health Risk Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2024-11-20 |
What the finished NCT04308382 record still lists
NCT04308382 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Health Risk Assessment is the first listed.
NCT04308382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04308382 about?
NCT04308382 is a clinical study titled "Evaluation of a Corporate Wellness Program". The purpose of this project is to determine the effectiveness of the corporate wellness program at Memorial Health System (MHS) in regards to: 1. Improvement of health of employees 2. Savings on health care expenses The corporate wellness program itself is not the object of the study, but rather t...
What is the current status of trial NCT04308382?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2020-08-24. Estimated completion is 2024-11-20.
What interventions are being tested in trial NCT04308382?
The interventions under investigation include: Health Risk Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04308382?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI